Veltkamp, M., Drent, M., & Baughman, R. P. (2016). Infliximab or biosimilars in sarcoidosis; to switch or not to switch?. Sarcoidosis, Vasculitis and Diffuse Lung Disease, 32(4), 280–283. Retrieved from https://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/5001